JPRN-jRCT2080222224未知3 期
Phase III study of T-3262G15% in the pediatric patients with mycoplasma pneumonia
Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)0 个研究点开始时间: 2013年9月17日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 1age old 至 <= 15age old（—）
- 性别
- All
入选标准
- •(1) Age: between 1 and 15 years old
- •(2) Sex: male or female
- •(3) Outpatient or inpatient
- •(4) Presence of symptom/findings of mycoplasma pneumonia
- •(5) Others
排除标准
- •(1) Medical history of allergy to any quinolone or macrolide antibacterial agents
- •(2) Pregnant females, being possibly pregnant, or lactating females
- •(3) Others
研究者
相似试验
未知
2 期
Phase II/III Study of S-877503 in Pediatric Patients with Attention-deficit/Hyperactivity DisorderJPRN-jRCT2080222070SHIONOGI & CO., LTD.
未知
2 期
Phase II/III Study of S-877503 in Pediatric Patients with Attention-deficit/Hyperactivity Disorder -Long term Extension StudyAttention-deficit/Hyperactivity DisorderJPRN-jRCT2080222071SHIONOGI & CO., LTD.
招募中
3 期
A Phase 3 study of S-217622 in pediatric participantsSARS-CoV-2 infectionJPRN-jRCT2031230140Gomez Juan Carlos120
未知
3 期
Phase 3 Clinical Study of S-4661 in pediatric patients with meningitis and other bacterial infectionsJPRN-jRCT2080221492SHIONOGI & CO., LTD.
招募中
2 期
TiNT: Trametinib in Neurofibromatosis type 1 associated tumoursPlexiform neurofibromatosisOptic pathway gliomaCancer - Children's - BrainCancer - Children's - OtherHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersNeurological - Other neurological disordersNeurofibromatosis type 1ACTRN12620001229965Australian and New Zealand Children's Haematology/Oncology Group120